PUBLISHER: The Business Research Company | PRODUCT CODE: 1947038
PUBLISHER: The Business Research Company | PRODUCT CODE: 1947038
A radiofrequency eye device is a medical technology that applies controlled radiofrequency energy to stimulate collagen production and enhance skin elasticity around the eyes. By delivering targeted heat to the underlying tissues, it promotes tightening and reduces visible signs of aging, including fine lines and wrinkles. These devices are designed to offer nonsurgical, minimally invasive eye rejuvenation with minimal recovery time.
The primary product categories of radiofrequency eye devices include monopolar, bipolar, multipolar, and other types. Monopolar RF devices use a single active electrode along with a grounding plate, allowing energy to penetrate deeper into tissues. Distribution channels include direct sales, online retail, and other platforms, with applications such as dry eye therapy, wrinkle reduction, skin tightening, and related treatments. These devices are used by a range of end users, including hospitals, ophthalmic clinics, ambulatory surgical centers, and other healthcare providers.
Tariffs have increased costs of imported RF devices, components, and microneedling modules, impacting ophthalmic clinics and hospitals in North America and Europe. Segments such as multipolar and fractional devices are most affected. Positive effects include encouraging domestic production and innovation in efficient and cost-effective RF eye devices.
The radiofrequency eye device market research report is one of a series of new reports from The Business Research Company that provides radiofrequency eye device market statistics, including radiofrequency eye device industry global market size, regional shares, competitors with a radiofrequency eye device market share, detailed radiofrequency eye device market segments, market trends and opportunities, and any further data you may need to thrive in the radiofrequency eye device industry. This radiofrequency eye device market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The radiofrequency eye device market size has grown rapidly in recent years. It will grow from $1.01 billion in 2025 to $1.17 billion in 2026 at a compound annual growth rate (CAGR) of 16.3%. The growth in the historic period can be attributed to rising demand for nonsurgical eye rejuvenation, technological advancements in radiofrequency devices, growing cosmetic awareness, availability of minimally invasive treatments, increasing disposable income.
The radiofrequency eye device market size is expected to see rapid growth in the next few years. It will grow to $2.12 billion in 2030 at a compound annual growth rate (CAGR) of 16.0%. The growth in the forecast period can be attributed to multipurpose RF devices, integration with skincare and monitoring apps, expansion in ophthalmic and cosmetic clinics, AI-assisted procedure guidance, innovation in device portability and precision. Major trends in the forecast period include monopolar radiofrequency devices, bipolar radiofrequency devices, multipolar radiofrequency devices, fractional radiofrequency devices, microneedling radiofrequency devices.
The increasing adoption of minimally invasive cosmetic procedures is expected to support the expansion of the radiofrequency eye device market. These procedures involve treatments that require little or no incision and minimal downtime, providing aesthetic enhancements with quicker recovery and lower risk. The preference for minimally invasive methods is growing as more patients seek safe and effective treatments that do not require extended recovery periods. Radiofrequency eye devices contribute to this trend by delivering controlled radiofrequency energy to the sensitive skin around the eyes, stimulating collagen production, tightening tissues, reducing fine lines and wrinkles, and improving skin texture with precision. These devices offer a non-surgical alternative with minimal recovery time. For example, in June 2023, the American Society of Plastic Surgeons reported that minimally invasive cosmetic procedures increased from 13.7 million to 14.7 million in 2023, marking a 7 percent rise, while surgical procedures rose by 5 percent during the same period. This increasing adoption is driving growth in the radiofrequency eye device market.
Leading companies in the radiofrequency eye device market are advancing artificial intelligence-based technologies for eye diagnostics, such as AI-assisted meibography analysis, to improve diagnostic accuracy and treatment outcomes for conditions such as dry eye and other surface disorders. AI-assisted meibography analysis involves the use of deep learning algorithms to automatically assess the structure and function of the meibomian glands through infrared imaging of the eyelids. This allows for early identification of meibomian gland dysfunction and helps guide more precise treatment plans. In November 2023, Lumenis Ltd., an ophthalmic technology company based in Israel, launched OptiPLUS, a dual-frequency radiofrequency device designed for dry-eye treatment. The system includes features such as automatic electrode detection, preset treatment protocols, and closed-loop temperature control to effectively target meibomian glands while also enhancing collagen around the eyes. This technology allows clinics to combine AI-generated diagnostics with personalized radiofrequency treatments, improving outcomes for patients with ocular surface conditions.
In September 2023, OCULUS Inc., a diagnostic equipment provider based in the United States, formed a partnership with LUVO to bring new intense pulse light and radiofrequency devices to the United States ophthalmic market. Through this collaboration, OCULUS aims to expand its range of treatment solutions, improve care options for eye health professionals, and strengthen its position in the specialty care segment. LUVO is a technology provider based in Canada that offers intense pulse light and radiofrequency devices designed for safe and effective use in clinical eye care.
Major companies operating in the radiofrequency eye device market are InMode Ltd, Lumenis Ltd, Venus Concept, YA-MAN Ltd, MiBo Medical Group, Alma Lasers, EndyMed Medical, Pollogen Ltd, BTL Industries, Candela Medical, Silk'n International, Guangzhou Beautylife Tech, Norlanya, AMIRO, Zemits LLC, Lutronic Corporation, Jeisys Medical, RejuvaMedica Ltd, HABI Medical, ThermoLift Technologies Ltd
North America was the largest region in the radiofrequency eye device market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the radiofrequency eye device market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the radiofrequency eye device market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The radiofrequency eye device market consists of revenues earned by entities by providing services such as non-surgical eye rejuvenation, wrinkle reduction, skin tightening, and overall improvement of skin appearance. The market value includes the value of related goods sold by the service provider or included within the service offering. The radiofrequency eye device market also includes sales of handheld radiofrequency eye treatment devices, tabletop radiofrequency systems, and multi-functional radiofrequency platforms. Values in this market are 'factory gate' values; that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Radiofrequency Eye Device Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses radiofrequency eye device market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for radiofrequency eye device ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The radiofrequency eye device market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.